Healthline

Side Effects of Copaxone: What You Need to Know

Copaxone is a prescription drug used to treat different types of multiple sclerosis (MS) in adults. It can cause side effects that range from mild to serious, including injection site reactions, ...
Business Wire

Teva’s COPAXONE® 40mg – Favorable Response from European Patent Office

COPAXONE ® (glatiramer acetate injection) is indicated for the treatment of patients with relapsing forms of multiple sclerosis. The most common side effects of COPAXONE ® are redness, pain, swelling, ...
FiercePharma

Treatment with COPAXONE® in Multiple Sclerosis Demonstrated Remyelination and Neuroprotective Effects in a Preclinical Set

Additional Preclinical Data to be Presented at the Fifth Joint Triennial Congress of ECTRIMS and ACTRIMS Further Elucidate the Anti-inflammatory Mechanism of COPAXONE® JERUSALEM--(BUSINESS WIRE)-- ...
FiercePharma

Teva Provides Update on COPAXONE® Litigation

JERUSALEM--(BUSINESS WIRE)--Jul. 26, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S.
Business Wire

Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes

AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...
FierceBiotech

COPAXONE® 15-YEAR STUDY IN MULTIPLE SCLEROSIS PATIENTS DEMONSTRATES ROBUST LONG-TERM EFFICACY AND SAFETY

- More than 80 percent of patients were able to walk unassisted following 15 years of treatment and average disease duration of 22 years - The majority of patients experienced either stable or ...